Open access
Oct 2026
Onabotulinum Toxin A (BoNTA) in the Treatment of Chronic and High-Frequency Episodic Migraine: A Real-World Study
In this retrospective uncontrolled cohort, reductions in headache frequency and other clinical improvements were observed during BoNTA treatment in patients with CM and HFEM, and these findings cannot establish the efficacy of BoNTA in HFEM.
F. Jiménez-Jiménez, Alba Cárcamo-Fonfría, Silvina Espada-Rubio et al.
· Pharmaceuticals · 0 citations